PIK3CA mutations are frequently associated with other gene mutations which are involved in significant cancer-related pathways, such as the Wnt/beta-catenin pathway and tyrosine kinase receptors K-Ras/BRAF/MAPK. The gene discussed is KRAS; the disease is cancer.